Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-09-07

AUTHORS

Shuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, Yuho Najima, Takeshi Kobayashi, Yukiyasu Ozawa, Yoshinobu Kanda, Shinichi Kako, Toshiro Kawakita, Ken-ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Hideyuki Nakazawa, Kazunori Imada, Junya Kanda, Takahiro Fukuda, Yoshiko Atsuta, Jun Aoki

ABSTRACT

Myeloablative conditioning with fludarabine/busulfan (Flu/Bu4) prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) is effective for acute myeloid leukemia. However, the effectiveness of Flu/Bu4 for myelodysplastic syndrome (MDS) remains poorly understood. Therefore, we retrospectively analyzed nationwide registry data in Japan from 2006 to 2018 and compared transplant outcomes of adult MDS patients receiving Flu/Bu4 and busulfan/cyclophosphamide (Bu4/Cy) using propensity score (PS) matching. The primary endpoint was overall survival (OS). Among 2,482 MDS patients, 153 patients were assigned each to the Flu/Bu4 and Bu4/Cy groups. The 3-year OS rates were 52.7% (95% confidence interval [CI], 43.8–60.8%) and 49.5% (95% CI, 40.8–57.6%) in the Flu/Bu4 and Bu4/Cy group, respectively (P = 0.548). The 3-year progression-free survival (P = 0.858), the cumulative incidence of relapse (P = 0.536), and cumulative incidence of non-relapse mortality (P = 0.684) were not significantly different between the two groups. According to the findings of subgroup analyses, no patient had a favorable OS when using either of the two regimens. In conclusion, although our PS-matched cohort mainly comprised older patients who had a low hematopoietic cell transplantation-comorbidity index and low-risk disease status, Flu/Bu4 could be an alternative to Bu4/Cy for MDS patients prior to allo-HSCT. More... »

PAGES

3008-3015

References to SciGraph publications

  • 2015-11-07. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data) in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2015-11-20. Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2007-07-16. New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2 in BONE MARROW TRANSPLANTATION
  • 2005-01-13. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome in LEUKEMIA
  • 2001-12-01. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling in BONE MARROW TRANSPLANTATION
  • 2019-03-11. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60–69 years with myelodysplastic syndrome in ANNALS OF HEMATOLOGY
  • 2005-11-24. Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity in LEUKEMIA
  • 2013-02-08. Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2015-12-07. Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML in BONE MARROW TRANSPLANTATION
  • 2012-12-03. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics in BONE MARROW TRANSPLANTATION
  • 2015-10-12. Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis in BONE MARROW TRANSPLANTATION
  • Journal

    TITLE

    Bone Marrow Transplantation

    ISSUE

    12

    VOLUME

    56

    Author Affiliations

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41409-021-01447-y

    DOI

    http://dx.doi.org/10.1038/s41409-021-01447-y

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1140914433

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/34489555


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Busulfan", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cyclophosphamide", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Graft vs Host Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Leukemia, Myeloid, Acute", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myelodysplastic Syndromes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Propensity Score", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transplantation Conditioning", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vidarabine", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Stem Cell and Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.26999.3d", 
              "name": [
                "Division of Stem Cell and Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kurosawa", 
            "givenName": "Shuhei", 
            "id": "sg:person.01210210271.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210210271.86"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Haematology, Kobe City Hospital Organization Kobe City Medical Centre General Hospital, Kobe, Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Haematology, Kobe City Hospital Organization Kobe City Medical Centre General Hospital, Kobe, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shimomura", 
            "givenName": "Yoshimitsu", 
            "id": "sg:person.013164233035.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013164233035.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan", 
              "id": "http://www.grid.ac/institutes/grid.174567.6", 
              "name": [
                "Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Itonaga", 
            "givenName": "Hidehiro", 
            "id": "sg:person.01221607161.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221607161.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.415479.a", 
              "name": [
                "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Najima", 
            "givenName": "Yuho", 
            "id": "sg:person.01214267464.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214267464.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.415479.a", 
              "name": [
                "Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kobayashi", 
            "givenName": "Takeshi", 
            "id": "sg:person.01355201036.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355201036.66"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan", 
              "id": "http://www.grid.ac/institutes/grid.414932.9", 
              "name": [
                "Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ozawa", 
            "givenName": "Yukiyasu", 
            "id": "sg:person.01165712107.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165712107.72"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Hematology, Jichi Medical University, Shimotsuke, Japan", 
              "id": "http://www.grid.ac/institutes/grid.410804.9", 
              "name": [
                "Division of Hematology, Jichi Medical University, Shimotsuke, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kanda", 
            "givenName": "Yoshinobu", 
            "id": "sg:person.0617055140.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617055140.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan", 
              "id": "http://www.grid.ac/institutes/grid.415020.2", 
              "name": [
                "Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kako", 
            "givenName": "Shinichi", 
            "id": "sg:person.0675760325.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675760325.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.415538.e", 
              "name": [
                "Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kawakita", 
            "givenName": "Toshiro", 
            "id": "sg:person.01021265022.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021265022.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412342.2", 
              "name": [
                "Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Matsuoka", 
            "givenName": "Ken-ichi", 
            "id": "sg:person.01125116105.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125116105.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412814.a", 
              "name": [
                "Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maruyama", 
            "givenName": "Yumiko", 
            "id": "sg:person.010321122573.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010321122573.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.415262.6", 
              "name": [
                "Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ota", 
            "givenName": "Shuichi", 
            "id": "sg:person.011176077202.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011176077202.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.263518.b", 
              "name": [
                "Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nakazawa", 
            "givenName": "Hideyuki", 
            "id": "sg:person.01132156055.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132156055.72"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan", 
              "id": "http://www.grid.ac/institutes/grid.460257.2", 
              "name": [
                "Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Imada", 
            "givenName": "Kazunori", 
            "id": "sg:person.0732511457.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732511457.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.258799.8", 
              "name": [
                "Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kanda", 
            "givenName": "Junya", 
            "id": "sg:person.01100640630.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100640630.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.272242.3", 
              "name": [
                "Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fukuda", 
            "givenName": "Takahiro", 
            "id": "sg:person.016452523632.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016452523632.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan", 
              "id": "http://www.grid.ac/institutes/grid.27476.30", 
              "name": [
                "Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan", 
                "Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Atsuta", 
            "givenName": "Yoshiko", 
            "id": "sg:person.01146754030.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146754030.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.272242.3", 
              "name": [
                "Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Aoki", 
            "givenName": "Jun", 
            "id": "sg:person.01264262573.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264262573.40"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s12185-015-1894-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036307316", 
              "https://doi.org/10.1007/s12185-015-1894-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1705770", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049898813", 
              "https://doi.org/10.1038/sj.bmt.1705770"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1703271", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016424594", 
              "https://doi.org/10.1038/sj.bmt.1703271"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12185-015-1907-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045343135", 
              "https://doi.org/10.1007/s12185-015-1907-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bmt.2015.238", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015544910", 
              "https://doi.org/10.1038/bmt.2015.238"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.leu.2403640", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050028904", 
              "https://doi.org/10.1038/sj.leu.2403640"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1756-8722-6-15", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035364116", 
              "https://doi.org/10.1186/1756-8722-6-15"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bmt.2012.244", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028358194", 
              "https://doi.org/10.1038/bmt.2012.244"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bmt.2015.297", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000925323", 
              "https://doi.org/10.1038/bmt.2015.297"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00277-019-03653-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1112678641", 
              "https://doi.org/10.1007/s00277-019-03653-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.leu.2404037", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042454383", 
              "https://doi.org/10.1038/sj.leu.2404037"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2021-09-07", 
        "datePublishedReg": "2021-09-07", 
        "description": "Myeloablative conditioning with fludarabine/busulfan (Flu/Bu4) prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) is effective for acute myeloid leukemia. However, the effectiveness of Flu/Bu4 for myelodysplastic syndrome (MDS) remains poorly understood. Therefore, we retrospectively analyzed nationwide registry data in Japan from 2006 to 2018 and compared transplant outcomes of adult MDS patients receiving Flu/Bu4 and busulfan/cyclophosphamide (Bu4/Cy) using propensity score (PS) matching. The primary endpoint was overall survival (OS). Among 2,482 MDS patients, 153 patients were assigned each to the Flu/Bu4 and Bu4/Cy groups. The 3-year OS rates were 52.7% (95% confidence interval [CI], 43.8\u201360.8%) and 49.5% (95% CI, 40.8\u201357.6%) in the Flu/Bu4 and Bu4/Cy group, respectively (P\u2009=\u20090.548). The 3-year progression-free survival (P\u2009=\u20090.858), the cumulative incidence of relapse (P\u2009=\u20090.536), and cumulative incidence of non-relapse mortality (P\u2009=\u20090.684) were not significantly different between the two groups. According to the findings of subgroup analyses, no patient had a favorable OS when using either of the two regimens. In conclusion, although our PS-matched cohort mainly comprised older patients who had a low hematopoietic cell transplantation-comorbidity index and low-risk disease status, Flu/Bu4 could be an alternative to Bu4/Cy for MDS patients prior to allo-HSCT.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41409-021-01447-y", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1096890", 
            "issn": [
              "0268-3369", 
              "1476-5365"
            ], 
            "name": "Bone Marrow Transplantation", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "12", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "56"
          }
        ], 
        "keywords": [
          "fludarabine/busulfan", 
          "busulfan/cyclophosphamide", 
          "myelodysplastic syndrome", 
          "myeloablative conditioning", 
          "overall survival", 
          "cumulative incidence", 
          "MDS patients", 
          "hematopoietic cell transplantation comorbidity index", 
          "allogeneic hematopoietic stem cell transplantation", 
          "propensity score-matched analysis", 
          "hematopoietic stem cell transplantation", 
          "CY group", 
          "adult MDS patients", 
          "non-relapse mortality", 
          "nationwide registry data", 
          "progression-free survival", 
          "stem cell transplantation", 
          "acute myeloid leukemia", 
          "propensity-score matching", 
          "transplant outcomes", 
          "primary endpoint", 
          "allo-HSCT", 
          "favorable OS", 
          "older patients", 
          "OS rates", 
          "cell transplantation", 
          "subgroup analysis", 
          "myeloid leukemia", 
          "registry data", 
          "patients", 
          "disease status", 
          "cyclophosphamide", 
          "busulfan", 
          "syndrome", 
          "incidence", 
          "survival", 
          "Score Matching", 
          "group", 
          "regimens", 
          "relapse", 
          "transplantation", 
          "leukemia", 
          "cohort", 
          "mortality", 
          "endpoint", 
          "outcomes", 
          "conclusion", 
          "conditioning", 
          "status", 
          "findings", 
          "index", 
          "rate", 
          "analysis", 
          "Bu4", 
          "Cys", 
          "data", 
          "effectiveness", 
          "alternative", 
          "Japan", 
          "PS", 
          "matching"
        ], 
        "name": "Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis", 
        "pagination": "3008-3015", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1140914433"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41409-021-01447-y"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "34489555"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41409-021-01447-y", 
          "https://app.dimensions.ai/details/publication/pub.1140914433"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T21:07", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_874.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41409-021-01447-y"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01447-y'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01447-y'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01447-y'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01447-y'


     

    This table displays all metadata directly associated to this object as RDF triples.

    375 TRIPLES      21 PREDICATES      108 URIs      89 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41409-021-01447-y schema:about N2e1a166abbc84e779d4497c16426c596
    2 N365080c81181435da40a3e40a17882ce
    3 N45e1abf8dc1f4b7b808a0180bf7fe5fe
    4 N4ad8f5b03b424fe5a0817d7733e701fa
    5 N825f482f716d45e2a2e358f19d9911c7
    6 N8a7ffb9dc3754ea685aba5e36e6f153e
    7 N8c9fda63c02c400b9b916fcd6e7a3e59
    8 Na119ffbc50c0427c83bb644f2c4d67a1
    9 Na7be9dfe54b9478cb68835be26934b24
    10 Nbba693a6d8ed4821bd193cf65caee33a
    11 Nd2c371c008d24297afd8b6956056fb91
    12 anzsrc-for:11
    13 anzsrc-for:1102
    14 schema:author N330fe03a7ff4487383c11079da77c6a7
    15 schema:citation sg:pub.10.1007/s00277-019-03653-7
    16 sg:pub.10.1007/s12185-015-1894-x
    17 sg:pub.10.1007/s12185-015-1907-9
    18 sg:pub.10.1038/bmt.2012.244
    19 sg:pub.10.1038/bmt.2015.238
    20 sg:pub.10.1038/bmt.2015.297
    21 sg:pub.10.1038/sj.bmt.1703271
    22 sg:pub.10.1038/sj.bmt.1705770
    23 sg:pub.10.1038/sj.leu.2403640
    24 sg:pub.10.1038/sj.leu.2404037
    25 sg:pub.10.1186/1756-8722-6-15
    26 schema:datePublished 2021-09-07
    27 schema:datePublishedReg 2021-09-07
    28 schema:description Myeloablative conditioning with fludarabine/busulfan (Flu/Bu4) prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) is effective for acute myeloid leukemia. However, the effectiveness of Flu/Bu4 for myelodysplastic syndrome (MDS) remains poorly understood. Therefore, we retrospectively analyzed nationwide registry data in Japan from 2006 to 2018 and compared transplant outcomes of adult MDS patients receiving Flu/Bu4 and busulfan/cyclophosphamide (Bu4/Cy) using propensity score (PS) matching. The primary endpoint was overall survival (OS). Among 2,482 MDS patients, 153 patients were assigned each to the Flu/Bu4 and Bu4/Cy groups. The 3-year OS rates were 52.7% (95% confidence interval [CI], 43.8–60.8%) and 49.5% (95% CI, 40.8–57.6%) in the Flu/Bu4 and Bu4/Cy group, respectively (P = 0.548). The 3-year progression-free survival (P = 0.858), the cumulative incidence of relapse (P = 0.536), and cumulative incidence of non-relapse mortality (P = 0.684) were not significantly different between the two groups. According to the findings of subgroup analyses, no patient had a favorable OS when using either of the two regimens. In conclusion, although our PS-matched cohort mainly comprised older patients who had a low hematopoietic cell transplantation-comorbidity index and low-risk disease status, Flu/Bu4 could be an alternative to Bu4/Cy for MDS patients prior to allo-HSCT.
    29 schema:genre article
    30 schema:isAccessibleForFree false
    31 schema:isPartOf N501479e5cad44866aa63455eca11d914
    32 N6df39e4e0e2b49a4ae835869da80a1d4
    33 sg:journal.1096890
    34 schema:keywords Bu4
    35 CY group
    36 Cys
    37 Japan
    38 MDS patients
    39 OS rates
    40 PS
    41 Score Matching
    42 acute myeloid leukemia
    43 adult MDS patients
    44 allo-HSCT
    45 allogeneic hematopoietic stem cell transplantation
    46 alternative
    47 analysis
    48 busulfan
    49 busulfan/cyclophosphamide
    50 cell transplantation
    51 cohort
    52 conclusion
    53 conditioning
    54 cumulative incidence
    55 cyclophosphamide
    56 data
    57 disease status
    58 effectiveness
    59 endpoint
    60 favorable OS
    61 findings
    62 fludarabine/busulfan
    63 group
    64 hematopoietic cell transplantation comorbidity index
    65 hematopoietic stem cell transplantation
    66 incidence
    67 index
    68 leukemia
    69 matching
    70 mortality
    71 myeloablative conditioning
    72 myelodysplastic syndrome
    73 myeloid leukemia
    74 nationwide registry data
    75 non-relapse mortality
    76 older patients
    77 outcomes
    78 overall survival
    79 patients
    80 primary endpoint
    81 progression-free survival
    82 propensity score-matched analysis
    83 propensity-score matching
    84 rate
    85 regimens
    86 registry data
    87 relapse
    88 status
    89 stem cell transplantation
    90 subgroup analysis
    91 survival
    92 syndrome
    93 transplant outcomes
    94 transplantation
    95 schema:name Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis
    96 schema:pagination 3008-3015
    97 schema:productId N2c6a1453d9114ae8ae9c237ab9222c3a
    98 N6b7138db3d974a5cac81ccfc4b31ca0c
    99 Nbebb07a5b9514cb29475dd08943878f5
    100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1140914433
    101 https://doi.org/10.1038/s41409-021-01447-y
    102 schema:sdDatePublished 2022-11-24T21:07
    103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    104 schema:sdPublisher Nba23475bc3a243b68a015ab15f57209f
    105 schema:url https://doi.org/10.1038/s41409-021-01447-y
    106 sgo:license sg:explorer/license/
    107 sgo:sdDataset articles
    108 rdf:type schema:ScholarlyArticle
    109 N256f471e131b4637a205123f204582d0 rdf:first sg:person.0732511457.53
    110 rdf:rest N2f7fbfa0541946b1ad8d1615f5e7038d
    111 N2c6a1453d9114ae8ae9c237ab9222c3a schema:name pubmed_id
    112 schema:value 34489555
    113 rdf:type schema:PropertyValue
    114 N2e1a166abbc84e779d4497c16426c596 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Retrospective Studies
    116 rdf:type schema:DefinedTerm
    117 N2f7fbfa0541946b1ad8d1615f5e7038d rdf:first sg:person.01100640630.10
    118 rdf:rest Nf2a2ecba711e480d8bc23c95a5d05053
    119 N330fe03a7ff4487383c11079da77c6a7 rdf:first sg:person.01210210271.86
    120 rdf:rest Nfe98ac5188854a70a27299a06f53848e
    121 N365080c81181435da40a3e40a17882ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Graft vs Host Disease
    123 rdf:type schema:DefinedTerm
    124 N449d7a6dead44c8eaa15e5a494098dc3 rdf:first sg:person.011176077202.18
    125 rdf:rest Naef2213964284c5ea71cc9d2a32de852
    126 N45e1abf8dc1f4b7b808a0180bf7fe5fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Humans
    128 rdf:type schema:DefinedTerm
    129 N4ad8f5b03b424fe5a0817d7733e701fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Vidarabine
    131 rdf:type schema:DefinedTerm
    132 N501479e5cad44866aa63455eca11d914 schema:volumeNumber 56
    133 rdf:type schema:PublicationVolume
    134 N5ead6e5a3160495bb88bc90056228d94 rdf:first sg:person.01355201036.66
    135 rdf:rest Nc03373fcb93848528b8419f4f1db723b
    136 N646d462bef22405ebc8358b3b017f73b rdf:first sg:person.0617055140.49
    137 rdf:rest N713a800aa14c49e4bbb9da0ea7059579
    138 N6b7138db3d974a5cac81ccfc4b31ca0c schema:name dimensions_id
    139 schema:value pub.1140914433
    140 rdf:type schema:PropertyValue
    141 N6df39e4e0e2b49a4ae835869da80a1d4 schema:issueNumber 12
    142 rdf:type schema:PublicationIssue
    143 N713a800aa14c49e4bbb9da0ea7059579 rdf:first sg:person.0675760325.07
    144 rdf:rest Nc78d8144e0144cd98a1dd0da0e7a3148
    145 N7545a7a74605482d85cb917aeb1e18ff rdf:first sg:person.010321122573.82
    146 rdf:rest N449d7a6dead44c8eaa15e5a494098dc3
    147 N815dd244f3734565a361b5ed7485ecb8 rdf:first sg:person.01264262573.40
    148 rdf:rest rdf:nil
    149 N825f482f716d45e2a2e358f19d9911c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Myelodysplastic Syndromes
    151 rdf:type schema:DefinedTerm
    152 N8a7ffb9dc3754ea685aba5e36e6f153e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Busulfan
    154 rdf:type schema:DefinedTerm
    155 N8c9fda63c02c400b9b916fcd6e7a3e59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Hematopoietic Stem Cell Transplantation
    157 rdf:type schema:DefinedTerm
    158 N9d326962368c487a8ccb20f4fbde3f3a rdf:first sg:person.01125116105.34
    159 rdf:rest N7545a7a74605482d85cb917aeb1e18ff
    160 Na119ffbc50c0427c83bb644f2c4d67a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Leukemia, Myeloid, Acute
    162 rdf:type schema:DefinedTerm
    163 Na7be9dfe54b9478cb68835be26934b24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Cyclophosphamide
    165 rdf:type schema:DefinedTerm
    166 Naef2213964284c5ea71cc9d2a32de852 rdf:first sg:person.01132156055.72
    167 rdf:rest N256f471e131b4637a205123f204582d0
    168 Nba23475bc3a243b68a015ab15f57209f schema:name Springer Nature - SN SciGraph project
    169 rdf:type schema:Organization
    170 Nbba693a6d8ed4821bd193cf65caee33a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Propensity Score
    172 rdf:type schema:DefinedTerm
    173 Nbebb07a5b9514cb29475dd08943878f5 schema:name doi
    174 schema:value 10.1038/s41409-021-01447-y
    175 rdf:type schema:PropertyValue
    176 Nc03373fcb93848528b8419f4f1db723b rdf:first sg:person.01165712107.72
    177 rdf:rest N646d462bef22405ebc8358b3b017f73b
    178 Nc78d8144e0144cd98a1dd0da0e7a3148 rdf:first sg:person.01021265022.19
    179 rdf:rest N9d326962368c487a8ccb20f4fbde3f3a
    180 Nd2c371c008d24297afd8b6956056fb91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Transplantation Conditioning
    182 rdf:type schema:DefinedTerm
    183 Nd7b680da5e354d1e95c632567c20fccc rdf:first sg:person.01146754030.08
    184 rdf:rest N815dd244f3734565a361b5ed7485ecb8
    185 Ne7482bb175a74d2e9676c5b656d0d224 rdf:first sg:person.01214267464.19
    186 rdf:rest N5ead6e5a3160495bb88bc90056228d94
    187 Nf2a2ecba711e480d8bc23c95a5d05053 rdf:first sg:person.016452523632.46
    188 rdf:rest Nd7b680da5e354d1e95c632567c20fccc
    189 Nfe98ac5188854a70a27299a06f53848e rdf:first sg:person.013164233035.00
    190 rdf:rest Nfed44ebbc2e24e419264b132cd82a833
    191 Nfed44ebbc2e24e419264b132cd82a833 rdf:first sg:person.01221607161.35
    192 rdf:rest Ne7482bb175a74d2e9676c5b656d0d224
    193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    194 schema:name Medical and Health Sciences
    195 rdf:type schema:DefinedTerm
    196 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    197 schema:name Cardiorespiratory Medicine and Haematology
    198 rdf:type schema:DefinedTerm
    199 sg:journal.1096890 schema:issn 0268-3369
    200 1476-5365
    201 schema:name Bone Marrow Transplantation
    202 schema:publisher Springer Nature
    203 rdf:type schema:Periodical
    204 sg:person.01021265022.19 schema:affiliation grid-institutes:grid.415538.e
    205 schema:familyName Kawakita
    206 schema:givenName Toshiro
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021265022.19
    208 rdf:type schema:Person
    209 sg:person.010321122573.82 schema:affiliation grid-institutes:grid.412814.a
    210 schema:familyName Maruyama
    211 schema:givenName Yumiko
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010321122573.82
    213 rdf:type schema:Person
    214 sg:person.01100640630.10 schema:affiliation grid-institutes:grid.258799.8
    215 schema:familyName Kanda
    216 schema:givenName Junya
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100640630.10
    218 rdf:type schema:Person
    219 sg:person.011176077202.18 schema:affiliation grid-institutes:grid.415262.6
    220 schema:familyName Ota
    221 schema:givenName Shuichi
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011176077202.18
    223 rdf:type schema:Person
    224 sg:person.01125116105.34 schema:affiliation grid-institutes:grid.412342.2
    225 schema:familyName Matsuoka
    226 schema:givenName Ken-ichi
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125116105.34
    228 rdf:type schema:Person
    229 sg:person.01132156055.72 schema:affiliation grid-institutes:grid.263518.b
    230 schema:familyName Nakazawa
    231 schema:givenName Hideyuki
    232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132156055.72
    233 rdf:type schema:Person
    234 sg:person.01146754030.08 schema:affiliation grid-institutes:grid.27476.30
    235 schema:familyName Atsuta
    236 schema:givenName Yoshiko
    237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146754030.08
    238 rdf:type schema:Person
    239 sg:person.01165712107.72 schema:affiliation grid-institutes:grid.414932.9
    240 schema:familyName Ozawa
    241 schema:givenName Yukiyasu
    242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165712107.72
    243 rdf:type schema:Person
    244 sg:person.01210210271.86 schema:affiliation grid-institutes:grid.26999.3d
    245 schema:familyName Kurosawa
    246 schema:givenName Shuhei
    247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210210271.86
    248 rdf:type schema:Person
    249 sg:person.01214267464.19 schema:affiliation grid-institutes:grid.415479.a
    250 schema:familyName Najima
    251 schema:givenName Yuho
    252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214267464.19
    253 rdf:type schema:Person
    254 sg:person.01221607161.35 schema:affiliation grid-institutes:grid.174567.6
    255 schema:familyName Itonaga
    256 schema:givenName Hidehiro
    257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221607161.35
    258 rdf:type schema:Person
    259 sg:person.01264262573.40 schema:affiliation grid-institutes:grid.272242.3
    260 schema:familyName Aoki
    261 schema:givenName Jun
    262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264262573.40
    263 rdf:type schema:Person
    264 sg:person.013164233035.00 schema:affiliation grid-institutes:None
    265 schema:familyName Shimomura
    266 schema:givenName Yoshimitsu
    267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013164233035.00
    268 rdf:type schema:Person
    269 sg:person.01355201036.66 schema:affiliation grid-institutes:grid.415479.a
    270 schema:familyName Kobayashi
    271 schema:givenName Takeshi
    272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355201036.66
    273 rdf:type schema:Person
    274 sg:person.016452523632.46 schema:affiliation grid-institutes:grid.272242.3
    275 schema:familyName Fukuda
    276 schema:givenName Takahiro
    277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016452523632.46
    278 rdf:type schema:Person
    279 sg:person.0617055140.49 schema:affiliation grid-institutes:grid.410804.9
    280 schema:familyName Kanda
    281 schema:givenName Yoshinobu
    282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617055140.49
    283 rdf:type schema:Person
    284 sg:person.0675760325.07 schema:affiliation grid-institutes:grid.415020.2
    285 schema:familyName Kako
    286 schema:givenName Shinichi
    287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675760325.07
    288 rdf:type schema:Person
    289 sg:person.0732511457.53 schema:affiliation grid-institutes:grid.460257.2
    290 schema:familyName Imada
    291 schema:givenName Kazunori
    292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732511457.53
    293 rdf:type schema:Person
    294 sg:pub.10.1007/s00277-019-03653-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112678641
    295 https://doi.org/10.1007/s00277-019-03653-7
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1007/s12185-015-1894-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1036307316
    298 https://doi.org/10.1007/s12185-015-1894-x
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1007/s12185-015-1907-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045343135
    301 https://doi.org/10.1007/s12185-015-1907-9
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1038/bmt.2012.244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028358194
    304 https://doi.org/10.1038/bmt.2012.244
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1038/bmt.2015.238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015544910
    307 https://doi.org/10.1038/bmt.2015.238
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1038/bmt.2015.297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000925323
    310 https://doi.org/10.1038/bmt.2015.297
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1038/sj.bmt.1703271 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016424594
    313 https://doi.org/10.1038/sj.bmt.1703271
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1038/sj.bmt.1705770 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049898813
    316 https://doi.org/10.1038/sj.bmt.1705770
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1038/sj.leu.2403640 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050028904
    319 https://doi.org/10.1038/sj.leu.2403640
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1038/sj.leu.2404037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042454383
    322 https://doi.org/10.1038/sj.leu.2404037
    323 rdf:type schema:CreativeWork
    324 sg:pub.10.1186/1756-8722-6-15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035364116
    325 https://doi.org/10.1186/1756-8722-6-15
    326 rdf:type schema:CreativeWork
    327 grid-institutes:None schema:alternateName Department of Haematology, Kobe City Hospital Organization Kobe City Medical Centre General Hospital, Kobe, Japan
    328 schema:name Department of Haematology, Kobe City Hospital Organization Kobe City Medical Centre General Hospital, Kobe, Japan
    329 rdf:type schema:Organization
    330 grid-institutes:grid.174567.6 schema:alternateName Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
    331 schema:name Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
    332 rdf:type schema:Organization
    333 grid-institutes:grid.258799.8 schema:alternateName Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    334 schema:name Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    335 rdf:type schema:Organization
    336 grid-institutes:grid.263518.b schema:alternateName Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan
    337 schema:name Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan
    338 rdf:type schema:Organization
    339 grid-institutes:grid.26999.3d schema:alternateName Division of Stem Cell and Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
    340 schema:name Division of Stem Cell and Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
    341 rdf:type schema:Organization
    342 grid-institutes:grid.272242.3 schema:alternateName Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
    343 schema:name Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
    344 rdf:type schema:Organization
    345 grid-institutes:grid.27476.30 schema:alternateName Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan
    346 schema:name Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan
    347 Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
    348 rdf:type schema:Organization
    349 grid-institutes:grid.410804.9 schema:alternateName Division of Hematology, Jichi Medical University, Shimotsuke, Japan
    350 schema:name Division of Hematology, Jichi Medical University, Shimotsuke, Japan
    351 rdf:type schema:Organization
    352 grid-institutes:grid.412342.2 schema:alternateName Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
    353 schema:name Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
    354 rdf:type schema:Organization
    355 grid-institutes:grid.412814.a schema:alternateName Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
    356 schema:name Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
    357 rdf:type schema:Organization
    358 grid-institutes:grid.414932.9 schema:alternateName Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    359 schema:name Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    360 rdf:type schema:Organization
    361 grid-institutes:grid.415020.2 schema:alternateName Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
    362 schema:name Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
    363 rdf:type schema:Organization
    364 grid-institutes:grid.415262.6 schema:alternateName Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
    365 schema:name Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
    366 rdf:type schema:Organization
    367 grid-institutes:grid.415479.a schema:alternateName Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
    368 schema:name Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
    369 rdf:type schema:Organization
    370 grid-institutes:grid.415538.e schema:alternateName Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
    371 schema:name Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
    372 rdf:type schema:Organization
    373 grid-institutes:grid.460257.2 schema:alternateName Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan
    374 schema:name Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan
    375 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...